PRF Technologies (PRFX) Common Equity (2019 - 2026)
PRF Technologies (PRFX) recorded Common Equity of $16.48 million in the quarter ended Jun 30, 2026, up 95.1% from $8.44 million a year earlier.
Powered by 
Analysis
PRF Technologies (PRFX) Common Equity (2019 - 2026) Analysis & Trends
As of Dec 31, 2025, PRF Technologies reported Common Equity of $9.29 million, up 409.3% from the prior year.
- Annual Common Equity has a five-year compound annual growth rate of -11.0% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Common Equity came in at $1.82 million in the year ended Dec 31, 2024 (-74.8%), $7.24 million in the year ended Dec 31, 2023 (-34.3%), $11.02 million in the year ended Dec 31, 2022 (-39.0%) and $18.08 million in the year ended Dec 31, 2021 (+8.8%).
- The figure for the quarter ended Jun 30, 2026 is the highest quarterly Common Equity since the quarter ended Mar 31, 2022.
- Peak year-over-year performance for Common Equity in the last five years was growth of 409.3% in the quarter ended Dec 31, 2025, against a decline of 79.2% in the quarter ended Mar 31, 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 85.49 Bn |
| 10 | PRF Technologies | 492,329.90 | -22.92 Mn | - | 16.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.48 Mn |
| Dec 31, 2025 | 9.29 Mn |
| Jun 30, 2025 | 8.44 Mn |
| Dec 31, 2024 | 1.82 Mn |
| Jun 30, 2024 | -2.04 Mn |
| Mar 31, 2024 | 1.85 Mn |
| Dec 31, 2023 | 7.24 Mn |
| Sep 30, 2023 | 8.64 Mn |
| Jun 30, 2023 | 6.97 Mn |
| Mar 31, 2023 | 8.89 Mn |
| Dec 31, 2022 | 11.02 Mn |
| Sep 30, 2022 | 13.42 Mn |
| Jun 30, 2022 | 15.20 Mn |
| Mar 31, 2022 | 16.70 Mn |
| Dec 31, 2021 | 18.08 Mn |
| Sep 30, 2021 | 10.48 Bn |
| Jun 30, 2021 | 19.01 Mn |
| Mar 31, 2021 | 20.40 Mn |
| Dec 31, 2020 | 16.62 Mn |
| Jun 30, 2020 | -14.16 Mn |
API Access
PRF Technologies Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PRFX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PRFX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PRFX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();